Is sepsis a risk factor for bleeding in adults with hematologic malignancies?

Registros relacionados

• Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
  por: Stanworth, S, et al.
  Publicado em: (2015)
• Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis
  por: Simon J. Stanworth, et al.
  Publicado em: (2015-06-01)
• Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
  por: Stanworth, S, et al.
  Publicado em: (2014)
• Observational study of alternative platelet parameters to predict bleeding risk in patients with hematological malignancies (ATHENA study)
  por: Estcourt, L, et al.
  Publicado em: (2013)
• Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
  por: Stanworth, S, et al.
  Publicado em: (2014)